Abdominal Ultrasound scan
General imaging

Abdominal Ultrasound

A universal platform for abdominal ultrasound

Worldwide obesity has nearly tripled since 1975, contributing to a host of abdominal diseases.1 One subset of abdominal disease – liver disease – accounts for 2 million deaths per year.2 Because ultrasound is widely available, cost-effective and does not use ionizing radiation, it is a valuable tool for the assessment of liver and other abdominal issues.

Demonstrated results in Abdominal Ultrasound

  1. 200%

    improved spatial resolution

    200%

    improved spatial resolution

    Super Resolution MVI offers an improvement of more than 200% in spatial resolution for EPIQ Contrast-enhanced Ultrasound.3

  2. 2x

    the sensitivity and resolution of MFI

    2x

    the sensitivity and resolution of MFI

    MicroFlow Imaging (MFI HD) offers 2x the sensitivity and resolution of MFI in assessing blood flow.4

  3. 54%

    reduction in number of button pushes

    54%

    reduction in number of button pushes

    NextGeneration AutoSCAN reduces button pushes by up to 54% with pixel-by-pixel real time optimization.5

Confidence in every system and every exam

Philips portfolio of ultrasound machines provides excellent imaging of the abdomen, even in technically difficult patients. The proprietary nSight Plus Imaging Architecture creates real-time images with exceptional resolution and uniformity.5 Philips exclusive technologies – including PureWave, ElastQ and Liver Fat Quantification (LFQ), Fusion and Navigation, and contrast-enhanced ultrasound – combine to quantify liver fat for the prevention, assessment and monitoring of fatty liver disease.

Quality, insights, workflow and support

  • Image quality: Achieve deep penetration to successfully image the region of interest regardless of the presence of fat tissue.
  • Advanced insights: Deliver evidence for treatment decisions and elevate your abdominal ultrasound capabilities with advanced insights, such as our comprehensive, four-part solution to assess liver disease.
  • Workflow: Our ultrasound systems are designed for efficient workflow and ease of use, regardless of operator experience.
  • Trusted partner: We offer support tailored to your needs, including comprehensive clinical application education.

Advanced tools for abdominal ultrasound

  • Next Gen Auto Scan improves image uniformity, adaptively adjusting image brightness at every pixel and improving transducer plunkability by reducing button pushes by 54%.4
  • Auto ElastQ is designed to improve the quality and consistency of the liver elastography study by providing assistance with the best frame selection and ROI location.
  • Philips Fusion and Navigation enables fusion between ultrasound and CT/MR/PET/CBCT images in under one minute.5
  • Philips contrast enhanced ultrasound (CEUS) provides exceptional detail throughout arterial, portal and late phase scanning.

Image gallery

  • Inferior vena cava
    Inferior vena cava ultrasound
  • Kidney with Renal Stone
    Kidney with renal stone scan
  • Pancreas
    Ultrasound image of pancreas
  • Liver & Common Bile Duct
    Liver and common bile duct scan
  • Kidney & Liver
    Kidney and liver ultrasound

The widespread use of this technology in a general population could be helpful in screening for advanced chronic liver disease, especially considering that a complete study can be done in under three minutes using a non-invasive method for chronic liver disease.

MD, PhD. Richard G. Barr
President, Radiology Consultant, Inc
Medical Director, Southwoods Imaging, Youngstown, OH
Radiology Consultant

Related procedures

  • Liver Ultrasound

    Discover the benefits of Philips ultrasound for liver procedures, including excellent image quality, advanced insights and efficient workflow.

Documentation

Introducing next-generation shear wave elastography
PDF|(2.89 MB)
Footnotes
  1. World Health Organization Fact Sheet. Obesity and overweight. June 9, 2021. www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  2. Asrani et al, Burden of liver disease in the world. Journal of hepatology, Vol 70, Issue 1, 2019.)
  3. Transducer dependent, EPIQ Elite only
  4. When comparing release 10 performance to release 7 performance
  5. Auto Registration Timing Study Report, 2015
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.